Rhabdomyosarcoma, Recurrent, Refractory Clinical Trials in Jinan, Shandong

Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents